Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Recruiting
N/A
Interventional Study
Health Behavior
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 26 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 350 (estimated)
- Sponsor
- St. Jude Children's Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Childhood Cancer Survivor Study (CCSS) Participants
* Age ≥26 years
* Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines
* No history of cardiomyopathy
* Has not had an echoc…
Contacts